LENZ Therapeutics
LENZ · NASDAQ
$3.19−$0.11 (−3.33%)TodayMarket closed ·
Prev close $3.30
Who owns LENZ
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 72.9% of LENZ’s shares.
- RA Capital Management, LP13.3%
- Alpha Wave Global, LP11.5%
- Fidelity Management & Research Company LLC11.4%
- Versant Ventures8.5%
- Next 6 largest institutions28.2%
- All other shareholders27.1%
| Holder | Shares | % of shares |
|---|---|---|
| RA Capital Management, LP | 4.18M | 13.33% |
| Alpha Wave Global, LP | 3.61M | 11.52% |
| Fidelity Management & Research Company LLC | 3.56M | 11.35% |
| Versant Ventures | 2.66M | 8.47% |
| BlackRock Institutional Trust Company, N.A. | 1.92M | 6.13% |
| Squarepoint Capital LLP | 1.75M | 5.57% |
| abrdn Inc. | 1.55M | 4.94% |
| Millennium Management LLC | 1.51M | 4.81% |
| Vanguard Capital Management, LLC | 1.10M | 3.50% |
| 72 Investment Holdings, LLC | 1.02M | 3.25% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Growth Company Fund | 889.22K | 2.84% |
| Vanguard Total Stock Market Index Fund | 819.61K | 2.61% |
| abrdn Healthcare Investors Fund (US) | 784.39K | 2.50% |
| C WorldWide Healthcare Select Fund | 700.00K | 2.23% |
| iShares Russell 2000 ETF | 536.41K | 1.71% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of LENZ in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Guerard Frederic | Award | 22.10K | — |
| Scheiner Zachary | Award | 22.10K | — |
| George Jeffrey P. | Award | 22.10K | — |
| Drapkin Kimberlee C | Award | 22.10K | — |
| RA Capital Healthcare Fund LP | Award | 22.10K | — |
| Thunen Shelley B | Award | 22.10K | — |
| MCCOLLUM JAMES W | Award | 22.10K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 10.56M
- Days to cover
- 13.78
- % of shares outstanding
- 33.69%
- Average daily volume
- 766.16K
- Change since last report
- −0.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.